Corey J. Manley, EVP and Chief Legal/Administrative Officer at Omnicell (OMCL), has demonstrated a consistent pattern of selling activity over the past two years, with no recorded purchases in SEC filings. Since February 2024, Manley has executed 24 transactions exclusively involving OMCL shares, all of which were sales or dispositions, totaling over $2 million in value. The most recent transactions include a $256,879 sale on March 16, 2026, and a $131,374 disposition on March 15, 2026, following earlier sales of $155,251 in February and $304,689 in January of the same year. The transactions appear to follow a structured pattern, with multiple sales clustered around mid-month dates, likely tied to scheduled vesting events or tax-related dispositions.
Manley’s trading history shows a clear emphasis on reducing his OMCL holdings, with seven sales in the last six months alone. The largest single sale occurred on January 8, 2026, at $304,689, while smaller dispositions—such as a $12,037 sale in December 2025—suggest incremental divestment rather than a single bulk exit. The absence of any buy transactions indicates a one-way flow of shares out of his holdings. While the filings do not specify the reasons for these sales, the regularity and timing suggest adherence to prearranged trading plans or routine portfolio management. OMCL remains the sole company in Manley’s disclosed transactions, reinforcing his concentrated position in the healthcare technology firm prior to these disposals.
AI-assisted summary